NetworkNewsBreaks

FridayNov 01, 2019 12:27 pm

NetworkNewsBreaks – Wonderfilm Media Corp. (TSX.V: WNDR) (OTCQB: WDRFF) Appoints PCG Advisory as Investor-Relations, Strategic-Communications Advisor

Wonderfilm Media (TSX.V: WNDR) (OTCQB: WDRFF) is a producer of high-quality feature films and episodic television with international appeal. An article discussing the company reads, “Earlier in October, Wonderfilm appointed PCG Advisory Inc., a leading investor-relations and digital-strategies firm, to serve as an advisor for its investor-relations and strategic communications. The change in IR advisors reflects new market-driven opportunities for Wonderfilm resulting from the unprecedented worldwide appetite for streamed media content (http://nnw.fm/kKMt0).” To view the full article, visit http://nnw.fm/0Cdpy About Wonderfilm Media Wonderfilm is a leading, publicly traded entertainment company with offices in Los Angeles and Vancouver, British Columbia. Wonderfilm’s…

Continue Reading

FridayNov 01, 2019 11:39 am

NetworkNewsBreaks – Soleno Therapeutics, Inc. (NASDAQ: SLNO) Secures $15.4 Million in Underwritten Public Offering

Soleno Therapeutics (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, has closed an underwritten public offering of 12,841,667 of its common stock shares, which includes 1,675,000 additional shares per the full exercise of the over-allotment option granted to the underwriters. According to the update, the offering resulted in gross proceeds of approximately $15.4 million to Soleno, with each of the shares sold at the public offering price of $1.20. Soleno intends to use the offering proceeds primarily for working capital and general corporate purposes. ROTH Capital Partners acted as co-manager for the offering.…

Continue Reading

FridayNov 01, 2019 11:06 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Proprietary Drug-Delivery System Featured in Peer-Reviewed Medical Journal

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms, recently announced that results of a 2018 clinical study evaluating the use of its proprietary drug-delivery system have been published in the peer-reviewed medical journal Advances in Therapy. (http://nnw.fm/Ap7Zx). An article discussing the company reads, “In its report, Advances in Therapy also referenced a second study published recently by a separate group of researchers that evaluated a comparable CBD dose with bioabsorption findings representative of the cannabinoid-edibles industry sector in general. The results indicate that the rate of bioabsorption of the CBD from the competitive 100 mg formulation was…

Continue Reading

FridayNov 01, 2019 10:00 am

NetworkNewsBreaks – Reed’s Inc. (NASDAQ: REED) Secures $7 Million in Underwritten Public Offering

Reed’s Inc. (NASDAQ: REED), owner of the nation’s leading portfolio of handcrafted, all-natural beverages, has closed an underwritten public offering of 11,666,667 shares of its common stock. According to the update, the offering resulted in approximately $7 million of gross proceeds to Reed’s Inc., with each of the shares sold at the public offering price of $0.60. Reed’s intends to use the offering’s proceeds to fund the growth of its business, new products, sales and marketing efforts, working capital, and for general corporate purposes. In addition, Reed’s has granted a 45-day option to the underwriter to purchase up to an…

Continue Reading

FridayNov 01, 2019 9:45 am

NetworkNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Announces Reverse Stock Split

Endonovo Therapeutics (OTCQB: ENDV), a commercial-stage developer of noninvasive Electroceutical(R) therapeutic devices, on Thursday announced its filing of a preliminary information statement with respect to a proposed reverse stock split of its common stock at a ratio of between 1 for 100 and 1-for-1,000. According to the update, the proposed reverse stock split effectiveness is contingent upon final SEC clearance of the Information Statement, mailing of the statement and a twenty-day waiting period, Endonovo’s sole director’s decision as to the final ratio of the reverse stock split, filing of a certificate of amendment to the company’s certificate of incorporation, and…

Continue Reading

FridayNov 01, 2019 9:18 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses Hemp Cigarettes on MoneyTV with Donald Baillargeon

Technology and investment company SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The program is syndicated internationally and covers money-focused topics, featuring various companies and in-depth interviews with CEOs and executives that offer insights into operations and future outlooks. MoneyTV is viewed in over 200 million households in more than 75 countries. This week’s program featured SinglePoint CEO Greg Lambrecht as he discussed the company’s recent endeavor into the hemp cigarette space. “This hemp cigarette business is really going to be huge,” SinglePoint CEO Greg Lambrecht stated in the interview. To view the full…

Continue Reading

ThursdayOct 31, 2019 3:15 pm

NetworkNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Sets Sights on National Expansion

Tacoma, Washington-based cannabis holding company IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3) is planning to expand its footprint throughout the United States, and aims to reach at least 318 stores in California and 225 stores in Oregon by January 2020. An article discussing the company reads, “The flagship product for IONIC is its vape pen line, which has done well in the marketplace, particularly in Washington state. This vaporizer product is currently ranked in the top 10 of such products in Washington state, which suggests that expansion into other states and distribution centers will likely be successful. Overall, vape…

Continue Reading

ThursdayOct 31, 2019 2:10 pm

NetworkNewsBreaks – Neutra Corp. (NTRR) Prepares to Launch Transdermal, CBD-Based, Pain-Relief Cream

Neutra Corp. (OTC: NTRR), an early-stage research and development company, is preparing to launch a new transdermal, hemp-based sports cream intended to provide pain relief for athletes whose workouts induce aches and pains. An article discussing the company reads, “The cream rollout is the latest product to market created under Neutra’s subsidiary VIVIS Corp., an emerging retail brand of hemp-based health and nutritional products acquired last month as Neutra’s retail presence. Vivis has a line of products that features a 99% or higher grade of hemp-extracted crystalline CBD, and a second product line in the works will feature an 80%…

Continue Reading

ThursdayOct 31, 2019 2:03 pm

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Ahead of Curve in New California Compliancy Law

Digital marketing and consumer-data-management technology company SRAX (NASDAQ: SRAX) is staying a step ahead of the competition as new privacy laws come into play in California. An article discussing the company reads, “While other companies are adjusting budgets to cover the cost of compliancy to a new California law by January 1, 2020, BIGtoken has already sidestepped the legal data issue because it requests users’ permission for data sharing when those users initially sign up for the platform. BIGtoken puts control in the hands of the consumer by providing the right to privacy, awareness and choice from the get-go (http://nnw.fm/oZiY0). Once…

Continue Reading

ThursdayOct 31, 2019 1:25 pm

NetworkNewsBreaks – Global Fiber Technologies, Inc. (GFTX) Engages Investor Relations Firm International Monetary

Global Fiber Technologies (OTCQB: GFTX), a New Jersey-based “textile fiber” technology company, today announced that the company has retained Newport Beach, CA-based International Monetary to develop and oversee a complete investor relations program and finance initiative. “We chose International Monetary because we wanted an experienced and well-connected investor relations firm that we felt was capable of keeping up with us, ready to get out there and communicate what we believe is a company with game changing technologies and trade secrets combined with a compelling value proposition, and the ability to exemplify our commitment to building shareholder value. This is a…

Continue Reading